Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | C086 |
Synonyms | |
Therapy Description |
C086 inhibits HSP90 and BCR-ABL, resulting in decreased proliferation of tumor cells, including imatinib-resistant cells (PMID: 25501124, PMID: 31802936). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
C086 | BCR-ABL Inhibitor 31 HSP90 Inhibitor 35 | C086 inhibits HSP90 and BCR-ABL, resulting in decreased proliferation of tumor cells, including imatinib-resistant cells (PMID: 25501124, PMID: 31802936). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|